Brief Report—Human Embryonic Stem Cell-Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes

Stem Cells - Tập 27 Số 2 - Trang 451-456 - 2009
B. Linju Yen1,2, Chan-Jung Chang2, Ko‐Jiunn Liu3, Yao‐Chang Chen4,5,2, Hsin-I Hu6,2, Chyi‐Huey Bai7, Men‐Luh Yen8,6
1Department of Obstetrics/Gynecology, Cathay General Hospital Sijhih, Taipei, Taiwan
2Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
3National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan
4Department of Forensic Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
5Department of Laboratory Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
6Department of Primary Care Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
7Central Laboratory, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
8Department of Obstetrics Gynecology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan

Tóm tắt

Abstract

The derivation of mesenchymal progenitors from human embryonic stem cells (hESCs) has recently been reported. We studied the immune characteristics of these hESC-derived mesenchymal progenitors (EMPs) and their interactions with T lymphocytes and natural killer cells (NKs), two populations of lymphocytes with important roles in transplantation immunology. EMPs express a number of bone marrow mesenchymal stromal cell (BMMSC) markers, as well as the hESC marker SSEA-4. Immunologically, EMPs do not express HLA-DR or costimulatory molecules. On the other hand, HLA-G, a nonclassic MHC I protein involved in mediating maternal-fetal tolerance, can be found on the surface of EMPs, and its expression is increased after interferon-γ stimulation. EMPs can suppress CD4+ or CD8+ lymphocyte proliferation, similar to BMMSCs. However, EMPs are more resistant to NK-mediated lysis than BMMSCs and can suppress the cytotoxic effects of activated NKs, as well as downregulating the NK-activating receptors NKp30 and NKp46. With their broad immunosuppressive properties, EMPs may represent a new potential cell source for therapeutic use.

Từ khóa


Tài liệu tham khảo

Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145

Reubinoff, 2000, Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro, Nat Biotechnol, 18, 399, 10.1038/74447

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143

Rao, 2001, Stem cells and aging: Expanding the possibilities, Mech Ageing Dev, 122, 713, 10.1016/S0047-6374(01)00224-X

Olivier, 2006, Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells, STEM CELLS, 24, 1914, 10.1634/stemcells.2005-0648

Barberi, 2005, Derivation of multipotent mesenchymal precursors from human embryonic stem cells, PLoS Med, 2, e161, 10.1371/journal.pmed.0020161

Lian, 2007, Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs, STEM CELLS, 25, 425, 10.1634/stemcells.2006-0420

Abeyta, 2004, Unique gene expression signatures of independently-derived human embryonic stem cell lines, Hum Mol Genet, 13, 601, 10.1093/hmg/ddh068

Chang, 2006, Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma, STEM CELLS, 24, 2466, 10.1634/stemcells.2006-0071

Gang, 2007, SSEA-4 identifies mesenchymal stem cells from bone marrow, Blood, 109, 1743, 10.1182/blood-2005-11-010504

Guillot, 2007, Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC, STEM CELLS, 25, 646, 10.1634/stemcells.2006-0208

Boquest, 2005, Isolation and transcription profiling of purified uncultured human stromal stem cells: Alteration of gene expression after in vitro cell culture, Mol Biol Cell, 16, 1131, 10.1091/mbc.e04-10-0949

Pérez-Villar, 1997, The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1, J Immunol, 158, 5736, 10.4049/jimmunol.158.12.5736

Rouas-Freiss, 1997, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proc Natl Acad Sci U S A, 94, 11520, 10.1073/pnas.94.21.11520

Bolton, 1989, Cellular requirements for renal allograft rejection in the athymic nude rat, J Exp Med, 169, 1931, 10.1084/jem.169.6.1931

Young, 2004, Immunobiology of natural killer lymphocytes in transplantation, Transplantation, 78, 1, 10.1097/01.TP.0000123764.10461.4C

Kärre, 1986, Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, Nature, 319, 675, 10.1038/319675a0

Maier, 2001, Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice, Nat Med, 7, 557, 10.1038/87880

Kitchens, 2006, The changing role of natural killer cells in solid organ rejection and tolerance, Transplantation, 81, 811, 10.1097/01.tp.0000202844.33794.0e

Fildes, 2008, Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation, J Heart Lung Transplant, 27, 203, 10.1016/j.healun.2007.11.571

Rasmusson, 2006, Immune modulation by mesenchymal stem cells, Exp Cell Res, 312, 2169, 10.1016/j.yexcr.2006.03.019

Sotiropoulou, 2006, Interactions between human mesenchymal stem cells and natural killer cells, STEM CELLS, 24, 74, 10.1634/stemcells.2004-0359

Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775

Poggi, 2005, Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: Role of NKp30 and NKG2D receptors, J Immunol, 175, 6352, 10.4049/jimmunol.175.10.6352

Lauwerys, 2000, Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18, J Immunol, 165, 1847, 10.4049/jimmunol.165.4.1847

Nasef, 2007, Immunosuppressive effects of mesenchymal stem cells: Involvement of HLA-G, Transplantation, 84, 231, 10.1097/01.tp.0000267918.07906.08

Gaunt, 2001, Immunological tolerance of the human fetus, Am J Perinatol, 18, 299, 10.1055/s-2001-17861

Moffett, 2006, Immunology of placentation in eutherian mammals, Nat Rev Immunol, 6, 584, 10.1038/nri1897

Drukker, 2002, Characterization of the expression of MHC proteins in human embryonic stem cells, Proc Natl Acad Sci U S A, 99, 9864, 10.1073/pnas.142298299

Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3

Götherström, 2004, Immunologic properties of human fetal mesenchymal stem cells, Am J Obstet Gynecol, 190, 239, 10.1016/j.ajog.2003.07.022

Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024